Status:

UNKNOWN

Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo Study

Lead Sponsor:

Mellitor

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Most patients with diabetes mellitus have to measure their blood glucose levels quite often, in order to maintain a proper glycemic control. Current methods of self-monitoring of blood glucose are inv...

Eligibility Criteria

Inclusion

  • Male/Female aged 18 and up.
  • Subject was scheduled for transudate/exudate liquid withdrawal.
  • Subject able to comprehend and give informed consent for participation in this study.
  • Signed Informed Consent Form

Exclusion

  • Known cognitive or psychiatric disorder.
  • Subjects with HIV.
  • Subject refuses to sign inform consent form.

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2010

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00746642

Start Date

October 1 2009

End Date

October 1 2010

Last Update

June 4 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hadassah Medical Organization

Jerusalem, Israel, 91120

Use of Mellitor Sensor for Continuous Glucose Monitoring - An Ex-Vivo Study | DecenTrialz